Featured in Prurigo NodularisPrurigo Nodularis News & ResearchAbrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic PruritusDecrease in Peak Pruritus Numeric Rating Scale for PN, chronic pruritus of unknown origin patientsBy Elana Gotkine (HealthDay News) | June 25, 2024Worst Itch Numeric Rating Scale Can Assess Itch in Prurigo NodularisModerate-to-strong correlations support convergent validity; rating scale sensitive to changeBy Dermsquared Editorial Team | June 12, 2024Nemolizumab Improves Symptoms in Prurigo NodularisTreatment efficacy seen in primary end points of itch response and Investigator's Global Assessment responseBy Elana Gotkine (HealthDay News) | October 26, 2023